Maiwald Magazine

Press Coverage

11 Mar 2025 - Press Coverage

Roche gets Illumina unit’s DNA testing patent revoked

Roche has successfully persuaded a European appeals panel to revoke a patent held by Illumina’s subsidiary, Verinata Health, for detecting fetal DNA in maternal blood. The European Patent Office (EPO) ruled that the patent lacked an inventive step, as a prior application f...

12 Feb 2025 - Press Coverage

Royalty Pharma Announces $250M R&D Funding Collaboration with Biogen

New York, NY, February 12, 2025 – Royalty Pharma (Nasdaq: RPRX) has entered into an agreement with Biogen to provide up to $250 million in research and development (R&D) funding for litifilimab, a first-in-class investigational biologic in Phase 3 tria...

28 Nov 2024 - Press Coverage

Swerving the matter of granting genetic scissor patents at the EPO

The European Patent Office (EPO) was expected to issue key rulings on CRISPR/Cas9 patents this autumn, but instead, legal uncertainty persists. Nobel Prize winners Emmanuelle Charpentier and Jennifer Doudna, pioneers of the technology, withdrew their patent applications befo...

Maiwald in the press

Publications

22 Apr 2025 - Publication

MAIinsight Issue 2 out now!

24 Mar 2025 - Publication

Statistics and Takeaways from Continued Application of G 2/21 by the EPO’s Boards of Appeal and First Impressions from the UPC on “Plausibility” epi Information, 1/2025

In G 2/21 of March 23, 2023, the Enlarged Board of Appeal (EBA) decided on the requirements for reliance on a purported technical effect for supporting inventive step, which i...

10 Mar 2025 - Publication

Germany permits service of claims on Chinese defendants by publication, Managing IP 2025

German courts now allow the service of claims on Chinese defendants by publication to ensure effective legal protection. The Regional Court of Frankfurt am Ma...

All publications

Events

Tue.

6 May 2025 |Upcoming|External Events

Maiwald at the LSPN North America Spring 2025 in Boston, May 6-7, 2025

Maiwald is joining one of the most influential IP conference in the life sciencesThe 7th Annual LSPN North America–Spring Conference is an important destination for cutting-edge insights into intellectual property challenges in pharmaceutical, biotechnology, and medical technology industries.We are excited to announce that Maiwald is a

Thu.

15 May 2025 |Upcoming|Seminar

Maiwald Seminar on May 15

Patent law news: EPO case law, software and UPC (Lectures will be held in German) We are delighted to invite you once again to our Maiwald seminar. The presentations will take place on May 15, 2025 from 14:00 in Munich in our seminar room in our Maiwald office. ...

Sat.

17 May 2025 |Upcoming|External Events

Maiwald at INTA’s 2025 Annual Meeting in San Diego

Connect with more than 10,000 top intellectual property professionals, business leaders, government officials, judges, NGOs, and solutions providers at the largest IP gathering of the year. Once again, we are excited to be part of INTA 2025 in San Diego!

Tue.

20 May 2025 |Upcoming|Vortag Live

Joint symposium with Oblon in Tokyo on May 20, 2025

The Oblon and Maiwald firms are pleased to invite you to a complimentary joint international symposium on: U.S. and European Patent Practice: Important Aspects for Practitioners At the 2025 joint symposium, we will together examine selected current aspects of protecting innovation...

All events

News and Releases

Maiwald Blog

EPO Board of Appeal 3.3.04 is setting the right standard for acknowledging novelty of non-medical use claims (T 1913/21)

EPO revokes Roche’s Patent on combination therapy of bevacizumab and paclitaxel for platinum-resistant ovarian cancer that was supported by results of Phase III AURELIA clinical trial

UPDATE: New proceedings before the Enlarged Board of Appeal: “G2/24 – Skin cleanser”

Press Coverage

Roche gets Illumina unit’s DNA testing patent revoked

Royalty Pharma Announces $250M R&D Funding Collaboration with Biogen

Swerving the matter of granting genetic scissor patents at the EPO

Staff News

Maiwald congratulates Dr. Anna Closs on passing the exam

Maiwald appoints Dr. Lukas Delvos and Dr. Jian Sun as Counsel

Maiwald congratulates on passing the exam

Publications

MAIinsight Issue 2 out now!

Statistics and Takeaways from Continued Application of G 2/21 by the EPO’s Boards of Appeal and First Impressions from the UPC on “Plausibility” epi Information, 1/2025

Germany permits service of claims on Chinese defendants by publication, Managing IP 2025

Awards

Maiwald voted one of the best commercial law firms of 2025 by brandeins and Statista

Managing IP EMEA Awards 2025

Chambers Germany 2025 rankings

Events

Maiwald at the LSPN North America Spring 2025 in Boston, May 6-7, 2025

Maiwald Seminar on May 15

Maiwald at INTA’s 2025 Annual Meeting in San Diego

Joint symposium with Oblon in Tokyo on May 20, 2025